The $2.65 million five-year grant from the National Institute on Drug Abuse (NIDA) will support research to understand how xylazine and fentanyl change the brain’s signaling pathways.
Published in JAMA Network Open, new findings are adding to a growing body of evidence demonstrating positive outcomes associated with telemedicine for treating opioid use disorder.
Aug. 31 marks International Overdose Awareness Day, a time when attention is directed toward raising awareness about opioid overdose and ways to reverse deadly effects. One such way is naloxone, which has become more available throughout Kentucky due to UK’s HEALing Communities Study.
The Foundation for Opioid Response Efforts (FORE) has selected the University of Kentucky College of Pharmacy as one of three higher education entities funded to improve access to medications for opioid use disorder in pharmacies and health care settings.
A new study suggests that children born to mothers who use opioids during pregnancy may be more likely to develop chronic diseases as adults, including cardiovascular and metabolic diseases.
University of Kentucky researchers are creating an innovative statewide surveillance system to inform prevention and response efforts aimed at reducing the burden of opioid use disorder in Kentucky.
FindHelpNow is a near-real-time substance use disorder treatment locator created by the University of Kentucky College of Public Health’s Kentucky Injury Prevention and Research Center (KIPRC).
The University of Kentucky is hosting its fifth annual Substance Use Research Event (SURE) April 24 in the UK Gatton Student Center. This free event showcases translational research conducted at UK focusing on substance use and substance use disorder.
A group of University of Kentucky researchers in the Substance Use Priority Research Area (SUPRA) is working to make studies more responsive and inclusive. The group formed a community advisory board, called the Survivors Union of the Bluegrass (SUB), including those who identify as people who use drugs and/or people in non-abstinence-based recovery.
